Bicycle Therapeutics (BCYC) Deferred Taxes (2022 - 2026)
Bicycle Therapeutics posted quarterly Deferred Taxes of -$241000.0 for Q1 2026, up 81.69% year-on-year from -$132645.8 in Q1 2025, and down 128.59% on a QoQ basis from $843000.0 in Q4 2025.
Bicycle Therapeutics (BCYC) has 5 years of Deferred Taxes data on file, last reported at -$241000.0 in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 81.69% year-over-year to -$241000.0; the trailing twelve-month figure through Mar 2026 stood at $225000.0 (up 103.9% YoY), and the FY2025 full-year result was -$850000.0, up 83.74% from the prior year.
- Deferred Taxes for Q1 2026 stood at -$241000.0, down from $843000.0 in the prior quarter.
- Across five years, Deferred Taxes topped out at $7.3 million in Q3 2023 and bottomed at -$3.3 million in Q3 2024.
- The 5-year median for Deferred Taxes is -$767000.0 (2024), against an average of -$418941.2.
- The widest annual swing landed in 2023, when Deferred Taxes jumped 810.06%; it then sank 266.67% in 2024.
- A 5-year view of Deferred Taxes shows it stood at -$1.5 million in 2022, then soared by 80.83% to -$282000.0 in 2023, then tumbled by 266.67% to -$1.0 million in 2024, then soared by 181.53% to $843000.0 in 2025, then sank by 128.59% to -$241000.0 in 2026.
- The last three Deferred Taxes figures came in at -$241000.0 (Q1 2026), $843000.0 (Q4 2025), and -$46000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -859,000.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | -65.30 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 96.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Bicycle Therapeutics | 326.82 Mn | 326.82 Mn | - | -241,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -241,000.00 |
| Dec 31, 2025 | 843,000.00 |
| Sep 30, 2025 | -46,000.00 |
| Jun 30, 2025 | -331,000.00 |
| Mar 31, 2025 | -1.32 Mn |
| Dec 31, 2024 | -1.03 Mn |
| Sep 30, 2024 | -3.32 Mn |
| Jun 30, 2024 | -110,000.00 |
| Mar 31, 2024 | -767,000.00 |
| Dec 31, 2023 | -282,000.00 |
| Sep 30, 2023 | 7.27 Mn |
| Jun 30, 2023 | -1.58 Mn |
| Mar 31, 2023 | -2.11 Mn |
| Dec 31, 2022 | -1.47 Mn |
| Sep 30, 2022 | -1.02 Mn |
| Jun 30, 2022 | -868,000.00 |
| Mar 31, 2022 | -748,000.00 |